Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells
W. Li, R. P. Sparks, C. Sun, Y. Yang, L. Pantano, R. Kirchner, A. Weilheimer, B. J. Toles, J. Y. Chen, S. P. Moran, V. Barrera, Z. Li, P. Zhou, M. L. Brassil, D. Wrobel, , A. C. Mullen
The paper identifies ABHD17B as a therapeutic target for liver fibrosis by showing its depletion inactivates hepatic stellate cells and reduces fibrosis in mice.
bioRxiv · Aug 7, 2023Cell Biology